跳至主要内容
临床试验/DRKS00015675
DRKS00015675已完成不适用

VIACORIND® In Daily Practice – Effectiveness and tolerability of VIACORIND® in hypertensive patients - VIACORIND®-IDP

Servier GmbH Deutschland0 个研究点目标入组 1,232 人开始时间: 2018年10月10日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
1,232

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • the patient has at least 18 years of age
  • - the patient is treated with VIACORIND® in compliance with the summary of product characteristics
  • - only patients for whom a therapy with VIACORIND® is clinically necessary and has already been planned before study start
  • - the patient is informed about participating in this NIS and transfer of clinical data; his/her written informed consent is obtained

排除标准

  • Patients under 18 years of age and incapable of giving their consent must not participate in this study
  • Patients with contraindications according to the summary of prodcut characteristics must not participate in this study

研究者

相似试验